The new FDA-cleared magnetic muscle stimulation (MMS) device is used to strengthen, tone, and firm the abdomen, buttocks, and thighs
EDINA, Minn. (September 4, 2019) – Zel Skin & Laser Specialists, a dermatologist-directed skin care clinic with locations in Minneapolis, Edina, and Plymouth, announced today the availability of the commercial evaluation of CoolTone™ by CoolSculpting.
“We were one of very few clinics in the country invited to participate in CoolSculpting clinical trials. Now, we are one of the first clinics in the county to participate in the beta-testing program for CoolTone”, said Dr. Brian Zelickson, founder of Zel Skin & Laser Specialists.
CoolTone has received FDA-clearance for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also indicated for strengthening, toning and firming of buttocks and thighs. Through the use of magnetic muscle stimulation (MMS), the treatment induces involuntary muscle contractions to strengthen muscle fibers. Stronger muscle fibers result in a more toned and defined appearance of the area treated.
The Edina location is seeking new patients to participate and provide feedback on overall treatment experience, pricing, and results. People interested in the procedure will be evaluated to determine if they are a good candidate and must complete four treatments over the course of two weeks. Patients can schedule a consultation by calling (952) 929-8888.
A dermatologist-directed skin care clinic led by Dr. Brian Zelickson, Zel Skin & Laser Specialists has three Minneapolis-metro locations that offer Medical Dermatology, Cosmetic Dermatology, Mohs Surgery, and Virtual Dermatology Visits. It has participated in 100+ clinical studies and seen more than 30,000 patients. Additionally, Zel offers more than 80 treatment options and 75 skin care products. The providers include Jennifer Biglow, MD, Elisabeth Hurliman, MD, Mary Meighan, MD, Brooke Moss, PA-C, MPH, Rachel Stevens, PA-C, Lauren Sundick, PA-C, Wendy Timmons, PA-C, Karl Vance, MD, and Brian Zelickson, MD.